[ CAS No. 69395-13-7 ] {[proInfo.proName]}

Name: 69395-13-7|4-(2-Hydroxyethyl)benzonitrile|98%
Brand: Ambeed
SKU: A179583
Price: 7.0 USD
Availability: InStock
Rating: 93 (28 reviews)

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

2D 3D

Structure of 69395-13-7 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 69395-13-7 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 69395-13-7 ]

SDS Specification

Alternatived Products of [ 69395-13-7 ]

Product Details of [ 69395-13-7 ]

CAS No. :	69395-13-7	MDL No. :	MFCD00052461
Formula :	C₉H₉NO	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	RBSJBNYPTGMZIH-UHFFFAOYSA-N
M.W :	147.17	Pubchem ID :	2800815
Synonyms :

Calculated chemistry of [ 69395-13-7 ]

Physicochemical Properties

Num. heavy atoms :	11
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.22
Num. rotatable bonds :	2
Num. H-bond acceptors :	2.0
Num. H-bond donors :	1.0
Molar Refractivity :	42.09
TPSA :	44.02 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-6.84 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.68
Log Po/w (XLOGP3) :	0.5
Log Po/w (WLOGP) :	1.09
Log Po/w (MLOGP) :	1.17
Log Po/w (SILICOS-IT) :	1.98
Consensus Log Po/w :	1.28

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-1.34
Solubility :	6.74 mg/ml ; 0.0458 mol/l
Class :	Very soluble
Log S (Ali) :	-0.99
Solubility :	14.9 mg/ml ; 0.101 mol/l
Class :	Very soluble
Log S (SILICOS-IT) :	-2.7
Solubility :	0.296 mg/ml ; 0.00201 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	1.35

Safety of [ 69395-13-7 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P280-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 69395-13-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 69395-13-7 ]
Downstream synthetic route of [ 69395-13-7 ]

[ 69395-13-7 ] Synthesis Path-Upstream 1~13

1
[ 69395-13-7 ]
[ 72054-56-9 ]

Yield	Reaction Conditions	Operation in experiment
91%	With carbon tetrabromide; triphenylphosphine In dichloromethane at 20℃; for 5 h;	To a stirred solution of 4-(2-hydroxyethyl)benzonitrile (1.0g ,6.8mmol,1eq.) in DCM (20 mL) was added CBr4 (4.5016g, 13.6mmol, 2.0 eq) and TPP (3.835g, 13.6mmol, 2.0 eq). The resulting solution was stirred at RT for 5h. Reaction was monitored TLC. Reaction was diluted with water and extracted with EtOAc. Organic layer was dried over sodium sulfate, filtered and the filtrated concentrated. The crude compound was isolated by column chromatography to get pure 4-(2-bromoethyl)benzonitrile (1.3 g, 91percent). LC-MS (method 23): Rt = 2.01 min; m/z = 210.05 (M+H⁺).

Reference： [1] Patent: WO2018/149986, 2018, A1, . Location in patent: Page/Page column 95
[2] Pharmazie, 1982, vol. 37, # 1, p. 13 - 16
[3] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 1, p. 65 - 68
[4] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1979, p. 1128 - 1132
[5] Patent: US5811459, 1998, A,

2
[ 69395-13-7 ]
[ 72054-56-9 ]

Reference： [1] Patent: US5340831, 1994, A,
[2] Patent: US5422358, 1995, A,

3
[ 69395-13-7 ]
[ 5462-71-5 ]

Reference： [1] Patent: WO2004/54584, 2004, A1, . Location in patent: Page/Page column 24
[2] Patent: US2005/20591, 2005, A1, . Location in patent: Page/Page column 13
[3] Patent: EP1612204, 2006, A1, . Location in patent: Page/Page column 46

4
[ 76113-58-1 ]
[ 69395-13-7 ]

Reference： [1] Journal of the American Chemical Society, 2012, vol. 134, # 30, p. 12466 - 12469
[2] Journal of the American Chemical Society, 2012, vol. 134, # 43, p. 18147 - 18147,1

5
[ 52798-01-3 ]
[ 69395-13-7 ]

Reference： [1] Chemistry - A European Journal, 2015, vol. 21, # 42, p. 14737 - 14741
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 2, p. 131 - 134

6
[ 873-74-5 ]
[ 69395-13-7 ]

Reference： [1] Journal of the American Chemical Society, 2012, vol. 134, # 30, p. 12466 - 12469
[2] Journal of the American Chemical Society, 2012, vol. 134, # 43, p. 18147 - 18147,1

7
[ 100-27-6 ]
[ 69395-13-7 ]

Reference： [1] Helvetica Chimica Acta, 1981, vol. 64, # 5, p. 1688 - 1703
[2] Pharmazie, 1982, vol. 37, # 1, p. 13 - 16

8
[ 103-45-7 ]
[ 69395-13-7 ]

Reference： [1] Helvetica Chimica Acta, 1981, vol. 64, # 5, p. 1688 - 1703

9
[ 544-92-3 ]
[ 104-10-9 ]
[ 69395-13-7 ]

Reference： [1] Journal of the American Chemical Society, 1982, vol. 104, # 7, p. 1937 - 1951

10
[ 13152-87-9 ]
[ 69395-13-7 ]

Reference： [1] Organic and Biomolecular Chemistry, 2003, vol. 1, # 14, p. 2499 - 2505

11
[ 143-33-9 ]
[ 104-10-9 ]
[ 69395-13-7 ]

Reference： [1] Helvetica Chimica Acta, 1981, vol. 64, # 5, p. 1688 - 1703

12
[ 5462-71-5 ]
[ 69395-13-7 ]

Reference： [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 2, p. 131 - 134

13
[ 104-10-9 ]
[ 69395-13-7 ]

Reference： [1] Pharmazie, 1982, vol. 37, # 1, p. 13 - 16

[ 69395-13-7 ] Synthesis Path-Downstream 1~88

1
[ 69395-13-7 ]
[ 72054-56-9 ]

Yield	Reaction Conditions	Operation in experiment
91%	With carbon tetrabromide; triphenylphosphine; In dichloromethane; at 20℃; for 5h;	To a stirred solution of 4-(2-hydroxyethyl)benzonitrile (1.0g ,6.8mmol,1eq.) in DCM (20 mL) was added CBr4 (4.5016g, 13.6mmol, 2.0 eq) and TPP (3.835g, 13.6mmol, 2.0 eq). The resulting solution was stirred at RT for 5h. Reaction was monitored TLC. Reaction was diluted with water and extracted with EtOAc. Organic layer was dried over sodium sulfate, filtered and the filtrated concentrated. The crude compound was isolated by column chromatography to get pure 4-(2-bromoethyl)benzonitrile (1.3 g, 91%). LC-MS (method 23): Rt = 2.01 min; m/z = 210.05 (M+H+).
	With phosphorus tribromide; In diethyl ether;	(B) To a mixture of 2-(4-cyanophenyl)ethanol (5 g) in diethyl ether was added phosphorus tribromide (3.94 ml) dropwise. The mixture was heated at reflux for 3 hours, poured into water (200 ml) and the organic layer washed with sodium bicarbonate (100 ml) and brine (100 ml), dried (magnesium sulphate), filtered and evaporated. There was thus obtained (4-cyanophenethyl)bromide (3.34 g).

Reference： [1]Patent: WO2018/149986,2018,A1 .Location in patent: Page/Page column 95
[2]Pharmazie,1982,vol. 37,p. 13 - 16
[3]ACS Medicinal Chemistry Letters,2014,vol. 5,p. 65 - 68
[4]Journal of the Chemical Society. Perkin transactions II,1979,p. 1128 - 1132
[5]Patent: US5811459,1998,A

2
[ 69395-13-7 ]
[ 166272-81-7 ]
4-chloro-3-[2-(4-cyano-phenyl)-ethoxy]-benzoic acid methyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2004,vol. 14,p. 2801 - 2805
[2]Journal of Medicinal Chemistry,2005,vol. 48,p. 3290 - 3312

3
[ 69395-13-7 ]
3-[2-(4-cyano-phenyl)-ethoxy]-4-fluoro-benzoic acid [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 3290 - 3312
[2]Bioorganic and Medicinal Chemistry Letters,2004,vol. 14,p. 2801 - 2805

4
[ 69395-13-7 ]
3-[2-(4-cyano-phenyl)-ethoxy]-4-fluoro-N-(3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-4-ylmethyl)-benzamide [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2005,vol. 48,p. 3290 - 3312
[2]Bioorganic and Medicinal Chemistry Letters,2004,vol. 14,p. 2801 - 2805

5
[ 69395-13-7 ]
4-chloro-3-[2-(4-cyano-phenyl)-ethoxy]-benzoic acid [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2004,vol. 14,p. 2801 - 2805

6
[ 69395-13-7 ]
4-chloro-3-[2-(4-cyano-phenyl)-ethoxy]-N-(3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-4-ylmethyl)-benzamide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2004,vol. 14,p. 2801 - 2805

7
[ 13152-87-9 ]
[ 69395-13-7 ]

Reference： [1]Organic and Biomolecular Chemistry,2003,vol. 1,p. 2499 - 2505

8
[ 69395-13-7 ]
N-[6-[2-(4-cyano-phenyl)-ethoxy]-9-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-8-p-tolylamino-9H-purin-2-yl]-isobutyramide [ No CAS ]

Reference： [1]Synlett,2002,p. 802 - 804

9
[ 69395-13-7 ]
[ 444594-33-6 ]

Reference： [1]Synlett,2002,p. 802 - 804

10
[ 69395-13-7 ]
[ 444594-40-5 ]

Reference： [1]Synlett,2002,p. 802 - 804

11
[ 69395-13-7 ]
N²-i-butyryl-8-N-(4-methylphenylamino)-O^5'-dimethoxytrityl-2'-deoxyguanosine [ No CAS ]

Reference： [1]Synlett,2002,p. 802 - 804

12
[ 69395-13-7 ]
N²-i-butyryl-8-N-(4-methylphenylamino)-O^3'-[(2-cyanoethoxy)-(N,N-diisopropylamino)phosphinyl]-O^5'-dimethoxytrityl-2'-deoxyguanosine [ No CAS ]

Reference： [1]Synlett,2002,p. 802 - 804

13
[ 69395-13-7 ]
toluene-3-sulfonic acid 3-[2-(4-aminomethyl-phenyl)-ethoxy]-phenyl ester [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2001,vol. 44,p. 3424 - 3439

14
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
[ 215245-00-4 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 345 - 347

15
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
Acetic acid 2-(4-{acetylamino-[(Z)-hydroxyimino]-methyl}-phenyl)-ethyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 345 - 347

16
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
3-isopropoxy-5-{2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-ethoxy}-phenol [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 345 - 347

17
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
acetic acid 3-isopropoxy-5-{2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-ethoxy}-phenyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 345 - 347

18
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
4-{2-[2-(3-isopropoxy-5-{2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-ethoxy}-phenoxymethyl)-phenyl]-ethyl}-phenol [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 345 - 347

19
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
3-{2-[2-(3-isopropoxy-5-{2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-ethoxy}-phenoxymethyl)-phenyl]-ethyl}-phenol [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 345 - 347

20
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
3-(4-{2-[3-isopropoxy-5-(2-{2-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-ethyl}-benzyloxy)-phenoxy]-ethyl}-phenyl)-5-methyl-[1,2,4]oxadiazole [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 345 - 347

21
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
3-(4-{2-[3-isopropoxy-5-(2-{2-[3-(tetrahydro-pyran-2-yloxy)-phenyl]-ethyl}-benzyloxy)-phenoxy]-ethyl}-phenyl)-5-methyl-[1,2,4]oxadiazole [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 345 - 347

22
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
4-[2-(3-{2-[2-(4-hydroxy-phenyl)-ethyl]-benzyloxy}-5-isopropoxy-phenoxy)-ethyl]-benzamidine; compound with acetic acid [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 345 - 347

23
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
4-[2-(3-{2-[2-(3-hydroxy-phenyl)-ethyl]-benzyloxy}-5-isopropoxy-phenoxy)-ethyl]-benzamidine; compound with acetic acid [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2000,vol. 10,p. 345 - 347

24
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
[ 287963-96-6 ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

25
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
[ 287964-01-6 ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

26
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
[ 287963-98-8 ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

27
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
4-{2-[7-(4-isopropyl-thiazol-2-ylmethoxy)-naphthalen-2-ylmethoxy]-ethyl}-benzoic acid [ No CAS ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

28
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
[ 287963-99-9 ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

29
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
4-{2-[7-(5-fluoro-benzothiazol-2-ylmethoxy)-naphthalen-2-ylmethoxy]-ethyl}-benzonitrile [ No CAS ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

30
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
4-{2-[7-(5-fluoro-benzothiazol-2-ylmethoxy)-naphthalen-2-ylmethoxy]-ethyl}-benzoic acid [ No CAS ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

31
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
4-{2-[7-(4-cyclobutyl-thiazol-2-ylmethoxy)-naphthalen-2-ylmethoxy]-ethyl}-benzoic acid [ No CAS ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

32
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
[ 287963-97-7 ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

33
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
4-{2-[7-(2,3-dichloro-thieno[3,2-b]pyridin-5-ylmethoxy)-naphthalen-2-ylmethoxy]-ethyl}-benzoic acid [ No CAS ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

34
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
[ 287964-02-7 ]

Reference： [1]European Journal of Medicinal Chemistry,2000,vol. 35,p. 439 - 447

35
[ 69395-13-7 ]
C₆H₅CH₂X [ No CAS ]
2-<4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl>ethyl alcohol [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1999,vol. 42,p. 691 - 705

36
[ 69395-13-7 ]
[ 215245-00-4 ]

Reference： [1]Tetrahedron Letters,1998,vol. 39,p. 7619 - 7622
[2]Patent: WO2015/186056,2015,A1

37
[ 69395-13-7 ]
[ 215245-03-7 ]

Reference： [1]Tetrahedron Letters,1998,vol. 39,p. 7619 - 7622
[2]Patent: WO2015/186056,2015,A1

38
[ 69395-13-7 ]
[ 215244-99-8 ]

Reference： [1]Tetrahedron Letters,1998,vol. 39,p. 7619 - 7622

39
[ 69395-13-7 ]
Acetic acid 3-(3-methyl-butoxy)-5-{2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-ethoxy}-phenyl ester [ No CAS ]

Reference： [1]Tetrahedron Letters,1998,vol. 39,p. 7619 - 7622

40
[ 69395-13-7 ]
[ 215245-09-3 ]

Reference： [1]Tetrahedron Letters,1998,vol. 39,p. 7619 - 7622

41
[ 69395-13-7 ]
[ 215245-08-2 ]

Reference： [1]Tetrahedron Letters,1998,vol. 39,p. 7619 - 7622

42
[ 69395-13-7 ]
4-{2-[3-(3-{2-[3-(4-Hydroxy-phenyl)-propoxy]-phenyl}-propoxy)-5-(3-methyl-butoxy)-phenoxy]-ethyl}-benzamidine; compound with acetic acid [ No CAS ]

Reference： [1]Tetrahedron Letters,1998,vol. 39,p. 7619 - 7622

43
[ 69395-13-7 ]
[ 1026968-34-2 ]

Reference： [1]Journal of Medicinal Chemistry,1997,vol. 40,p. 2085 - 2101

44
[ 69395-13-7 ]
{6-[2-(4-Methylsulfanylcarbonimidoyl-phenyl)-ethoxy]-1-oxo-3,4-dihydro-1H-isoquinolin-2-yl}-acetic acid tert-butyl ester [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1997,vol. 40,p. 2085 - 2101

45
[ 69395-13-7 ]
[ 173169-07-8 ]

Reference： [1]Helvetica Chimica Acta,1995,vol. 78,p. 1705 - 1737

46
[ 69395-13-7 ]
[ 173169-42-1 ]

Reference： [1]Helvetica Chimica Acta,1995,vol. 78,p. 1705 - 1737

47
[ 69395-13-7 ]
5'-O-(dimethoxytrityl)-O⁴-<2-(4-cyanophenyl)ethyl>-3'-O-<2-(4-nitrophenyl)ethylsulfonyl>uridine [ No CAS ]

Reference： [1]Helvetica Chimica Acta,1995,vol. 78,p. 1705 - 1737

48
[ 69395-13-7 ]
5'-O-(dimethoxytrityl)-O⁴-<2-(4-cyanophenyl)ethyl>-2'-O-<2-(4-nitrophenyl)ethylsulfonyl>uridine [ No CAS ]

Reference： [1]Helvetica Chimica Acta,1995,vol. 78,p. 1705 - 1737

49
[ 69395-13-7 ]
5'-O-(dimethoxytrityl)-O⁴-<2-(4-cyanophenyl)ethyl>-2',3'-bis-O-<2-(4-nitrophenyl)ethylsulfonyl>uridine [ No CAS ]

Reference： [1]Helvetica Chimica Acta,1995,vol. 78,p. 1705 - 1737

50
[ 69395-13-7 ]
[ 119744-97-7 ]

Reference： [1]Journal of Medicinal Chemistry,1989,vol. 32,p. 1108 - 1118

51
[ 69395-13-7 ]
4-(2-Ethylamino-ethyl)-benzonitrile; hydrobromide [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1989,vol. 32,p. 1108 - 1118

52
[ 69395-13-7 ]
2-Amino-N-[2-(4-cyano-phenyl)-ethyl]-N-ethyl-acetamide; hydrochloride [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1989,vol. 32,p. 1108 - 1118

53
[ 69395-13-7 ]
[ 119745-54-9 ]

Reference： [1]Journal of Medicinal Chemistry,1989,vol. 32,p. 1108 - 1118

54
[ 69395-13-7 ]
(R)-2-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-5-guanidino-pentanoic acid ([2-(4-cyano-phenyl)-ethyl]-ethyl-carbamoyl}-methyl)-amide; compound with acetic acid [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,1989,vol. 32,p. 1108 - 1118

55
[ 100-27-6 ]
[ 69395-13-7 ]

Reference： [1]Helvetica Chimica Acta,1981,vol. 64,p. 1688 - 1703
[2]Pharmazie,1982,vol. 37,p. 13 - 16

56
[ 69395-13-7 ]
[ 69395-14-8 ]

Reference： [1]Helvetica Chimica Acta,1981,vol. 64,p. 1688 - 1703

57
[ 69395-13-7 ]
2,4-Dicyanostyrol [ No CAS ]

Reference： [1]Helvetica Chimica Acta,1981,vol. 64,p. 1688 - 1703
[2]Helvetica Chimica Acta,1981,vol. 64,p. 1688 - 1703

58
[ 69395-13-7 ]
[ 79536-94-0 ]

Reference： [1]Helvetica Chimica Acta,1981,vol. 64,p. 1688 - 1703

59
[ 69395-13-7 ]
[ 79536-80-4 ]

Reference： [1]Helvetica Chimica Acta,1981,vol. 64,p. 1688 - 1703

60
[ 69395-13-7 ]
[ 79536-83-7 ]

Reference： [1]Helvetica Chimica Acta,1981,vol. 64,p. 1688 - 1703

61
[ 69395-13-7 ]
[ 69497-20-7 ]

Reference： [1]Helvetica Chimica Acta,1981,vol. 64,p. 1688 - 1703

62
[ 69395-13-7 ]
Phosphoric acid 2-(4-cyano-phenyl)-ethyl ester (2R,3S,5R)-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2-trityloxymethyl-tetrahydro-furan-3-yl ester; compound with triethyl-amine [ No CAS ]

Reference： [1]Helvetica Chimica Acta,1981,vol. 64,p. 1688 - 1703

63
[ 103-45-7 ]
[ 69395-13-7 ]

Reference： [1]Helvetica Chimica Acta,1981,vol. 64,p. 1688 - 1703

64
[ 69395-13-7 ]
[ 80632-18-4 ]

Reference： [1]Journal of the American Chemical Society,1982,vol. 104,p. 1937 - 1951

65
[ 69395-13-7 ]
[ 82098-50-8 ]